|
MRPL19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63014046705712E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62525548574877E-12 |
| Normal-vs-Stage2 |
4.82109999699887E-08 |
| Normal-vs-Stage3 |
2.08669999999245E-05 |
| Normal-vs-Stage4 |
2.17110000000353E-06 |
| Stage1-vs-Stage2 |
5.525000E-01 |
| Stage1-vs-Stage3 |
7.924200E-02 |
| Stage1-vs-Stage4 |
5.977200E-01 |
| Stage2-vs-Stage3 |
4.286200E-01 |
| Stage2-vs-Stage4 |
9.353400E-01 |
| Stage3-vs-Stage4 |
5.779400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
9.4329988264974E-11 |
| Normal-vs-Asian |
1.768020E-01 |
| Caucasian-vs-AfricanAmerican |
1.960620E-01 |
| Caucasian-vs-Asian |
1.481640E-01 |
| AfricanAmerican-vs-Asian |
4.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
1.59559999657333E-08 |
| Male-vs-Female |
2.596000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.90309998263183E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.73228098532263E-12 |
| Normal-vs-Extreme_Obese |
1.147360E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.702630E-01 |
| Normal_Weight-vs-Obese |
8.301800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.799370E-01 |
| Extreme_Weight-vs-Obese |
4.981600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.375230E-01 |
| Obese-vs-Extreme_Obese |
3.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.117300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.65401026208656E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.13450027150463E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.998400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.687950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.100100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.654220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.739800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.296400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.91240365157819E-11 |
| Normal-VS-KIRP CIMP |
4.397600E-01 |
| Normal-VS-Unclassified PRCC |
5.72449998514912E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.240300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.57689999969702E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
2.594400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.477500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.781800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.256700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.72715225139109E-14 |
| Normal-vs-N1 |
1.195840E-04 |
| Normal-vs-N2 |
1.017510E-04 |
| N0-vs-N1 |
1.451860E-02 |
| N0-vs-N2 |
9.218600E-01 |
| N1-vs-N2 |
2.742600E-01 |
|
|
